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Supplemental Figure Legends 
 
Figure S1. Parkin-mediated proteolysis of mitochondrial outer membrane proteins 
is dependent on the ubiquitin ligase activity of Parkin and is induced by disruption 
of the electrical potential of mitochondria.  
(A) Lack of Parkin expression in parental HeLa S3 cells. Total cell lysates were isolated 
from HeLa S3 and HeLa S3 cells expressing exogenous Parkin. Immunoblots were 
probed with antibodies against Parkin and actin (loading control). (B) Less efficient 
proteolysis by the Parkin mutant R275W. Clonal HeLa S3 cells exogenously expressing 
wild-type Parkin or the ubiquitin ligase mutant R275W were treated with 20 µM CCCP 
for the indicated time. Total cell lysates were isolated, and immunoblot analysis was used 
to detect the indicated proteins. (C) Outer membrane protein proteolyis induced by 
valinomycin but not rotenone. Clonal HeLa S3 cells expressing Parkin or the parental 
HeLa S3 cells were treated with DMSO (vehicle), 2 µM valinomycin, or 200 nM 
rotenone for the indicated times. Total cell lysates were isolated, and the indicated 
proteins were detected by immunoblot analysis. 
 
Figure S2. Overexpression of the K48R ubiquitin mutant partially suppresses 
mitophagy in Parkin-expressing HeLa cells.  
Clonal HeLa cells expressing Parkin were transiently transfected with GFP-tagged wild-
type or K48R ubiquitin. 48 hours post-transfection, cells were treated with a 100 min 
pulse of 20 µM CCCP. 24 hours after the CCCP pulse, cells were fixed and 
immunostained for Hsp60. Cells that showed complete mitophagy were identified as 
GFP-positive cells that were negative for Hsp60. Error bars represent standard errors 
from 3 independent experiments; 500 cells were analyzed per experiment. The p-value 
was calculated by a 2-tail student t test. 
 
Figure S3. Parkin-dependent degradation of Tom20 and dispersion of mitochondria. 
(A) Parental HeLa cells do not show CCCP-induced loss of Tom20. HeLa cells not 
expressing Parkin were treated with DMSO (control) or 20 µM CCCP for 4 hours. Fixed 
cells were stained for Tom20 (red), Hsp60 (green), and nuclei (DAPI, blue). Insets show 
enlarged views of the boxed area. Note that, without exogenous Parkin expression, HeLa 
cells do not show accumulation of Tom20-negative mitochondria or mitochondrial 
aggregation in response to CCCP. (B) Degradation of Tom20 in Parkin-expressing cells 
induced by CCCP. Parkin-expressing HeLa cells were treated with 20 µM CCCP for 4 
hours (upper panel) or 24 hours (lower panel). Fixed cells were stained for Tom20 (red), 
the matrix protein TRAP-1 (green), and nuclei (DAPI, blue). In the bottom panel, the 
mitochondrial aggregate is Tom20-negative but Hsp60-positive. (C) Same as (B), except 
a different matrix protein F1β (green) was detected. Note the presence of Tom20-
negative/Hsp60-positive mitochondria. (D) Temporal dynamics of Tom20-
negative/Hsp60-positive mitochondria.  Parkin-expressing HeLa cells were pretreated 
with DMSO (vehicle) or the proteasome inhibitor epoxomicin (2 µM) for 2 hours prior to 
treatment with CCCP (20 µM) for the indicated times. Fixed cells were stained for 
Tom20 (red), Hsp60 (green), and nuclei (DAPI, blue). Scale bars equal 10 µm.  
 
Figure S4. Inhibition of the 26S proteasome does not inhibit Parkin translocation to 
mitochondria, but inhibits mitophagy in HeLa, SH-SY5Y, and MEF cells.  
(A) Inhibition of the 26S proteasome does not affect Parkin translocation to 
mitochondria. Parkin-expressing HeLa cells were pre-treated with DMSO (vehicle) or 20 
µM MG132 for 2 hours, followed by incubation in the presence or absence of CCCP (20 
µM) for 4 hours. Formalin-fixed cells were stained for Hsp60 (green), Parkin (red), and 
nuclei (DAPI, blue). Scale bar equals 10 µm. (B) Quantitation of the experiment in (A). 
Parkin translocation to mitochondria was scored by co-localization with Hsp60. Results 
represent the mean from 2 independent experiments; 100 cells were scored per 
experiment. (C) The proteasome inhibitor epoxomicin prevents degradation of Tom20. 
Parkin-expressing HeLa cells were pretreated with DMSO (vehicle) or epoxomicin (2 
µM) for 2 hours, followed by treatment with CCCP (20 µM) for 4 hours (4 h), or pulse 
treatment for 100 min followed by incubation without CCCP for 12 hours (12 h). Fixed 
cells were stained for Hsp60 (green), Tom20 (red), and nuclei (DAPI, blue). Insets show 
enlarged views of the boxed area. (D) Quantitation of the 4 h time point in (C). Each cell 
was scored into one of the 5 indicated bins, depending on the number of Tom20-
negative/Hsp60-positive mitochondria found. Error bars represent standard deviations 
from 3 independent experiments; 100 cells were scored per experiment. (E) Quantitation 
of the 12 h time point in (C). Each cell was scored as having fragmented mitochondria, 
tubular mitochondria, or no mitochondria. Error bars represent standard deviation from 3 
independent experiments; 100 cells were analyzed per experiment. (F) Epoxomicin 
prevents Tom20 degradation and mitophagy in SH-SY5Y cells. SH-SY5Y cells with 
exogenous Parkin were pretreated with DMSO (vehicle) or epoxomicin (2 µM) for 2 
hours, followed by treatment with CCCP (20 µM) for 4 hours (4 h), or pulse treatment for 
100 min followed by incubation without CCCP for 24 hours (24 h). Immunostaining was 
performed as in (C). In the top panel, insets show enlarged views of the boxed area. 
Arrowheads mark an example of a dispersed mitochondrion positive for Hsp60, but 
negative for Tom20. Scale bars in A, C, F equal 10 µm. (G) MG132 abrogates CCCP-
induced mitophagy in MEFs. Wild-type MEFs expressing EGFP-Parkin were pretreated 
with DMSO (vehicle) or MG132 (5 µM), followed by treatment with CCCP (20 µM) for 
24 hours. Cells were fixed and stained for Hsp60 and nuclei (DAPI). Cells that underwent 
complete loss of mitochondria were identified as EGFP- and DAPI-positive cells with no 
Hsp60 signal. Error bars represents standard deviations from 3 independent experiments; 
200 cells were analyzed per experiment. 
 
Supplementary Table 1 ⏐MitoCarta proteins with decreased abundance in mitochondria of CCCP-treated cells 
Leading IPIs 
Leading Gene 
Names Leading Protein Descriptions 
Overall 
Normalized 
Ratio* 
Overall 
Significance^ 
IPI00412274 MFN1 Isoform 3 of Mitofusin-1 0.09 6.94E-18 
IPI00293073 MFN1 Mitochondrial transmembrane GTPase FZO-2 0.10 1.14E-23 
IPI00642329 MFN2 Isoform 1 of Mitofusin-2 0.10 2.51E-35 
IPI00015602 TOMM70A Mitochondrial import receptor subunit TOM70 0.13 3.78E-40 
IPI00807412 NT5C3 Isoform 2 of Cytosolic 5'-nucleotidase 3 0.15 1.03E-24 
IPI00432452 RHOT1 Isoform 1 of Mitochondrial Rho GTPase 1 0.16 4.29E-15 
IPI00219778 SLMO2 Protein slowmo homolog 2 0.17 6.01E-15 
IPI00877136;IPI000
19477;IPI00743132 SLC25A39 
solute carrier family 25, member 39 isoform 
a;Isoform 1 of Solute carrier family 25 member 
39;Isoform 2 of Solute carrier family 25 member 
39 0.18 3.17E-10 
IPI00032038 CPT1A 
Isoform 1 of Carnitine O-palmitoyltransferase 1, 
liver isoform 0.23 1.62E-21 
IPI00218144 COX17 Cytochrome c oxidase copper chaperone 0.23 6.06E-11 
IPI00329552 MOSC2 
Isoform 1 of MOSC domain-containing protein 2, 
mitochondrial 0.26 6.67E-10 
IPI00020510 CISD1 CDGSH iron sulfur domain-containing protein 1 0.26 8.74E-18 
IPI00001638 PRELID1 PRELI domain-containing protein 1, mitochondrial 0.28 3.07E-07 
IPI00002251 PDP2 
[Pyruvate dehydrogenase [acetyl-transferring]]-
phosphatase 2, mitochondrial 0.30 2.09E-08 
IPI00007266 ALAS1 
cDNA FLJ56039, highly similar to 5-
aminolevulinate synthase, nonspecific, 
mitochondrial 0.30 6.95E-08 
IPI00916131;IPI004
47419;IPI00514470 PISD;C22orf30 
Protein;Isoform 1 of Phosphatidylserine 
decarboxylase proenzyme;Phosphatidylserine 
decarboxylase 0.32 2.28E-07 
IPI00013829 TRIAP1 TP53-regulated inhibitor of apoptosis 1 0.34 4.56E-07 
IPI00446798 MTCP1 Protein p8 MTCP-1 0.34 1.03E-06 
IPI00328383;IPI004
78497;IPI00910479 SLC25A46 
Putative uncharacterized protein SLC25A46 
(Fragment);Solute carrier family 25 member 
46;cDNA FLJ60882 0.37 2.20E-06 
IPI00828198;IPI003
05258 MOSC1 
Isoform 2 of MOSC domain-containing protein 1, 
mitochondrial;Isoform 1 of MOSC domain-
containing protein 1, mitochondrial 0.39 1.39E-07 
IPI00171445 ATAD1 ATPase family AAA domain-containing protein 1 0.39 1.84E-07 
IPI00552793;IPI006
04730;IPI00013279 CHCHD7 
coiled-coil-helix-coiled-coil-helix domain 
containing 7 isoform b;coiled-coil-helix-coiled-
coil-helix domain containing 7 isoform d;Coiled-
coil-helix-coiled-coil-helix domain-containing 
protein 7 0.41 1.35E-05 
IPI00844249;IPI006
40749 GPAM 
Glycerol-3-phosphate acyltransferase, 
mitochondrial;Glycerol 3-phosphate 
acyltransferase, mitochondrial 0.42 3.39E-04 
IPI00031118 ALKBH7 Alkylated DNA repair protein alkB homolog 7 0.42 1.45E-04 
IPI00328161;IPI006
40341 FKBP8 
Isoform 2 of FK506-binding protein 8;Isoform 1 of 
FK506-binding protein 8 0.43 2.81E-06 
Mitochondria from Parkin-expressing HeLa S3 cells with and without CCCP (2 hours) were compared.   
IPI00465059 RHOT2 Isoform 1 of Mitochondrial Rho GTPase 2 0.44 4.94E-06 
IPI00061229 OMA1 
Isoform 1 of Metalloendopeptidase OMA1, 
mitochondrial 0.45 1.17E-04 
IPI00290614 ENDOG Endonuclease G, mitochondrial 0.45 1.56E-04 
IPI00830136;IPI005
52131;IPI00045660;
IPI00646750 C1orf31 
Isoform 2 of Uncharacterized protein 
C1orf31;cDNA FLJ60021, moderately similar to 
Protein transport protein Sec61 subunit alpha 
isoform 1;Isoform 1 of Uncharacterized protein 
C1orf31;Isoform 3 of Uncharacterized protein 
C1orf31 0.47 2.63E-05 
IPI00303722 FAM136A Protein FAM136A 0.51 1.01E-05 
IPI00016745;IPI007
59584 FPGS 
Isoform Mitochondrial of Folylpolyglutamate 
synthase, mitochondrial;Isoform Cytoplasmic of 
Folylpolyglutamate synthase, mitochondrial 0.53 4.50E-03 
IPI00910782;IPI000
16699 MTFR1;- 
cDNA FLJ61576, highly similar to Mitochondrial 
fission regulator 1;Mitochondrial fission regulator 
1 0.54 1.02E-03 
IPI00046828 CCDC58 Coiled-coil domain-containing protein 58 0.54 4.57E-05 
IPI00007052 FIS1 Mitochondrial fission 1 protein 0.55 1.33E-03 
IPI00025344 NDUFS6 
NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 6, mitochondrial 0.55 5.84E-04 
IPI00171459 HSDL1 Hydroxysteroid dehydrogenase-like protein 1 0.57 3.50E-03 
IPI00555597;IPI000
32903 PTRH2 
Peptidyl-tRNA hydrolase 2, mitochondrial 
precursor;Peptidyl-tRNA hydrolase 2, 
mitochondrial 0.57 2.04E-04 
IPI00329696 FAM82B Regulator of microtubule dynamics protein 1 0.57 1.20E-03 
IPI00478450;IPI004
72058 NDUFB11 
Isoform 2 of NADH dehydrogenase [ubiquinone] 1 
beta subcomplex subunit 11, 
mitochondrial;Neuronal protein 0.57 1.31E-03 
IPI00215901;IPI002
18988 AK2 
Isoform 1 of Adenylate kinase isoenzyme 2, 
mitochondrial;Isoform 2 of Adenylate kinase 
isoenzyme 2, mitochondrial 0.57 2.40E-04 
IPI00065063 DHRS1 Dehydrogenase/reductase SDR family member 1 0.58 4.74E-03 
IPI00008418;IPI002
19865 DIABLO 
Diablo homolog, mitochondrial precursor;Isoform 
2 of Diablo homolog, mitochondrial 0.59 5.12E-04 
IPI00301204 RDH13 Retinol dehydrogenase 13 0.60 2.61E-03 
IPI00011770 NDUFA4 
NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 4 0.62 5.47E-03 
IPI00296190;IPI006
46289;IPI00646889 C10orf58 
Uncharacterized protein C10orf58;25 kDa 
protein;Putative uncharacterized protein C10orf58 0.63 6.38E-03 
IPI00028491 AGPAT5 
1-acyl-sn-glycerol-3-phosphate acyltransferase 
epsilon 0.63 6.85E-03 
IPI00001589 TIMM13 
Mitochondrial import inner membrane translocase 
subunit Tim13 0.64 2.31E-03 
IPI00013459;IPI007
91036;IPI00556190 NDUFB5 
NADH dehydrogenase [ubiquinone] 1 beta 
subcomplex subunit 5, mitochondrial;22 kDa 
protein;NDUFB5 protein 0.64 8.53E-03 
IPI00028376 TIMM8A 
Mitochondrial import inner membrane translocase 
subunit Tim8 A 0.65 3.23E-03 
IPI00419266 NDUFA6 
NADH dehydrogenase (ubiquinone) 1 alpha 
subcomplex, 6, 14kDa 0.65 3.51E-03 
IPI00020332 ARG2 Arginase-2, mitochondrial 0.68 7.41E-03 
*Combined ratio from three independent mass spectrometry experiments consisting of two independent biological 
samples, and one technical replicate. The ratio represents the protein level in mitochondria of CCCP-treated cells 
divided by the level in untreated cells.  
^Corresponds to the significance in MaxQuant 	  
Supplementary Table 2⏐MitoCarta proteins enriched in mitochondria of CCCP-treated cells 
Leading IPIs 
Leading Gene 
Names 
Leading Protein 
Descriptions 
Overall 
Normalized 
Ratio* 
Overall 
Significance^ 
IPI00026781 FASN Fatty acid synthase 4.08 4.03E-07 
IPI00216298 TXN Thioredoxin 3.20 2.12E-05 
IPI00220301 PRDX6 Peroxiredoxin-6 3.19 3.71E-03 
IPI00604590; 
IPI00795292 
NME2:NME1-
NME2;NME2 
Nucleoside diphosphate 
kinase;NME1-NME2 protein 2.36 1.20E-03 
IPI00217966 LDHA 
Isoform 1 of L-lactate 
dehydrogenase A chain 2.10 4.33E-03 
IPI00219217 LDHB 
L-lactate dehydrogenase B 
chain 1.96 8.75E-03 
Mitochondria from Parkin-expressing HeLa S3 cells with and without CCCP (2 hours) were compared. 
     *Combined ratio from three independent mass spectrometry experiments consisting of two independent     
samples and one technical replicate. The ratio represents the protein level in mitochondria of CCCP-treated cells 
divided by the level in untreated cells.  
^Corresponds to significance in MaxQuant 	  
Supplementary Table 3⏐Non-MitoCarta proteins enriched in mitochondria of CCCP-treated 
cells	  
Leading 
IPIs 
Leading 
Gene 
Names 
Leading Protein 
Descriptions 
Overall 
Normalize
d Ratio* 
Overall 
Significance^ 
IPI0000525
4 PARK2 
Isoform 1 of E3 ubiquitin-
protein ligase parkin 13.5 4.42E-20 
IPI0017933
0 
UBB:RPS27
A:UBC 
ubiquitin and ribosomal protein 
S27a precursor 8.9 9.58E-15 
	   	  
IPI0078385
5;IPI008719
41;IPI00299
920;IPI0088
7954 
NBR1;LOC7
27732;LOC10
0133166 
neighbor of BRCA1 gene 
1;Isoform 1 of Next to BRCA1 
gene 1 protein;69 kDa 
protein;hypothetical protein 
isoform 2 8.3 2.90E-06 
IPI0023541
2;IPI008717
42;IPI00146
935;IPI0055
5883;IPI000
37283;IPI00
473085 DNM1L 
cDNA FLJ56381, highly similar 
to Dynamin-1-like 
protein;cDNA FLJ55044, highly 
similar to Dynamin-1-like 
protein;Isoform 1 of Dynamin-1-
like protein;Isoform 2 of 
Dynamin-1-like protein;Isoform 
5 of Dynamin-1-like 
protein;Isoform 4 of Dynamin-1-
like protein 6.3 4.78E-07 
IPI0017947
3 SQSTM1 Isoform 1 of Sequestosome-1 5.8 1.75E-06 
IPI0015146
2;IPI002204
82 
MAP1LC3B2
;MAP1LC3B 
Microtubule-associated proteins 
1A/1B light chain 3 beta 
2;Microtubule-associated 
proteins 1A/1B light chain 3B 5.4 3.70E-06 
IPI0000914
6 TRAFD1 
TRAF-type zinc finger domain-
containing protein 1 4.9 1.48E-04 
IPI0021962
2 PSMA2 Proteasome subunit alpha type-2 4.2 8.08E-05 
IPI0047930
6 PSMB5 Proteasome subunit beta type-5 4.2 4.21E-04 
IPI0064019
7;IPI000204
16 TPP2 
Tripeptidyl peptidase 
II;Tripeptidyl-peptidase 2 4.1 2.18E-03 
IPI0047244
2;IPI000168
32;IPI00871
889 PSMA1 
Isoform Long of Proteasome 
subunit alpha type-1;Isoform 
Short of Proteasome subunit 
alpha type-1;Proteasome subunit 
alpha type 4.0 5.38E-04 
IPI0002800
4 PSMB3 Proteasome subunit beta type-3 4.0 6.20E-04 
IPI0000081
1 PSMB6 Proteasome subunit beta type-6 3.9 2.30E-04 
IPI0064212
6 KIAA1618 Isoform 1 of Protein ALO17 3.9 1.38E-03 
IPI0003146
1 GDI2 
cDNA FLJ60299, highly similar 
to Rab GDP dissociation 
inhibitor beta 3.8 1.76E-04 
IPI0000822
3;IPI006425 RAD23B 
UV excision repair protein 
RAD23 homolog B;cDNA 3.7 4.55E-03 
49 FLJ56531, highly similar to UV 
excision repair protein RAD23 
homolog B 
IPI0002962
3 PSMA6 Proteasome subunit alpha type-6 3.7 1.18E-03 
IPI0055595
6 PSMB4 Proteasome subunit beta type-4 3.7 1.96E-03 
IPI0002417
5 PSMA7 
Isoform 1 of Proteasome subunit 
alpha type-7 3.7 1.29E-03 
IPI0029915
5;IPI007902
07 PSMA4 
Proteasome subunit alpha type-
4;27 kDa protein 3.6 4.70E-04 
IPI0041924
9;IPI001711
99 PSMA3 
Isoform 1 of Proteasome subunit 
alpha type-3;Isoform 2 of 
Proteasome subunit alpha type-3 3.6 4.85E-04 
IPI0000549
5;IPI002198
63;IPI00607
670;IPI0087
2048;IPI008
95831;IPI00
895820 ATXN3 
Isoform 1 of Ataxin-3;Isoform 2 
of Ataxin-3;ATXN3 protein;42 
kDa protein;ataxin 3 isoform 
3;ataxin 3 isoform 4 3.6 6.08E-03 
IPI0001344
6 PSCA Prostate stem cell antigen 3.6 2.63E-03 
IPI0001394
9;IPI009084
10 SGTA 
Small glutamine-rich 
tetratricopeptide repeat-
containing protein alpha;cDNA 
FLJ56566, highly similar to 
Small glutamine-rich 
tetratricopeptiderepeat-
containing protein A 3.5 3.01E-03 
IPI0021902
9 GOT1 
Aspartate aminotransferase, 
cytoplasmic 3.5 7.23E-04 
IPI0002635
8 
GABARAPL
2 
Gamma-aminobutyric acid 
receptor-associated protein-like 
2 3.4 7.88E-04 
IPI0002183
1 PRKAR1A 
cAMP-dependent protein kinase 
type I-alpha regulatory subunit 3.3 4.16E-03 
IPI0002501
9 PSMB1 Proteasome subunit beta type-1 3.3 2.66E-03 
IPI0002409
5 ANXA3 Annexin A3 3.3 4.85E-03 
IPI0000781
2 ATP6V1B2 
V-type proton ATPase subunit 
B, brain isoform 3.3 1.64E-05 
IPI0087346
6;IPI002184
93 HPRT1 
Putative uncharacterized protein 
HPRT1;Hypoxanthine-guanine 
phosphoribosyltransferase 3.2 5.49E-03 
IPI0029192
2 PSMA5 Proteasome subunit alpha type-5 3.2 9.68E-04 
IPI0002744
2 AARS 
Alanyl-tRNA synthetase, 
cytoplasmic 3.2 3.54E-03 
IPI0037552
7;IPI008560
84;IPI00442
268;IPI0064
4730;IPI009 IMPDH1 
inosine monophosphate 
dehydrogenase 1 isoform 
a;inosine monophosphate 
dehydrogenase 1 isoform 
c;inosine monophosphate 3.2 1.70E-03 
16697;IPI00
916378;IPI0
0647813 
dehydrogenase 1 isoform 
d;Isoform 3 of Inosine-5'-
monophosphate dehydrogenase 
1;IMP (Inosine monophosphate) 
dehydrogenase 1, isoform 
CRA_d;inosine monophosphate 
dehydrogenase 1 isoform 
f;Isoform 2 of Inosine-5'-
monophosphate dehydrogenase 
1 
IPI0015464
5;IPI007946
13 TBC1D15 
Isoform 1 of TBC1 domain 
family member 15;Isoform 2 of 
TBC1 domain family member 
15 3.2 6.18E-03 
IPI0090311
9;IPI000051
02;IPI00642
393 SMS 
45 kDa protein;Isoform 1 of 
Spermine synthase;Isoform 2 of 
Spermine synthase 3.2 6.36E-03 
IPI0032963
3 TARS 
Threonyl-tRNA synthetase, 
cytoplasmic 3.1 4.26E-03 
IPI0002744
4 SERPINB1 Leukocyte elastase inhibitor 3.1 1.96E-03 
IPI0002056
7 ARHGAP1 
cDNA FLJ60782, highly similar 
to Rho-GTPase-activating 
protein 1 3.1 7.38E-03 
IPI0000385
6 ATP6V1E1 
V-type proton ATPase subunit E 
1 3.1 4.77E-03 
IPI0000173
4 PSAT1 
cDNA FLJ56437, highly similar 
to Phosphoserine 
aminotransferase 2.9 6.62E-03 
IPI0046502
8 TPI1 
Isoform 1 of Triosephosphate 
isomerase 2.9 7.60E-05 
IPI0000781
4 ATP6V1C1 
V-type proton ATPase subunit C 
1 2.9 7.24E-03 
IPI0000768
2 ATP6V1A 
V-type proton ATPase catalytic 
subunit A 2.9 2.45E-03 
IPI0041345
1;IPI007493
98 SERPINB6 
Putative uncharacterized protein 
DKFZp686I04222;Serpin B6 2.8 4.43E-03 
IPI0047918
6;IPI002206
44 PKM2 
cDNA FLJ56065, highly similar 
to Pyruvate kinase isozyme 
M1;Isoform M1 of Pyruvate 
kinase isozymes M1/M2 2.8 1.25E-04 
IPI0029151
0 IMPDH2 
Inosine-5'-monophosphate 
dehydrogenase 2 2.8 2.96E-03 
IPI0002746
3 S100A6 Protein S100-A6 2.8 9.70E-03 
IPI0001415
1 PSMD6 
26S proteasome non-ATPase 
regulatory subunit 6 2.7 6.22E-03 
IPI0001380
8 ACTN4 Alpha-actinin-4 2.6 5.46E-03 
IPI0055556
5 HSP90AB4P 
Putative heat shock protein HSP 
90-beta 4 2.6 9.08E-03 
IPI0015668
9 VAT1 
Synaptic vesicle membrane 
protein VAT-1 homolog 2.6 5.89E-03 
IPI0079633 ALDOA 45 kDa protein;Fructose- 2.6 4.26E-04 
3;IPI004654
39 
bisphosphate aldolase A 
IPI0078409
0 CCT8 
T-complex protein 1 subunit 
theta 2.6 6.45E-03 
IPI0029056
6 TCP1 
T-complex protein 1 subunit 
alpha 2.5 7.02E-03 
IPI0001226
8 PSMD2 
26S proteasome non-ATPase 
regulatory subunit 2 2.5 6.38E-04 
IPI0032980
1;IPI008723
79 ANXA5 
Annexin A5;Putative 
uncharacterized protein ANXA5 
(Fragment) 2.5 7.84E-03 
IPI0001595
4 SAR1A GTP-binding protein SAR1a 2.5 7.87E-03 
IPI0021901
8 GAPDH 
Glyceraldehyde-3-phosphate 
dehydrogenase 2.5 6.83E-04 
IPI0001767
2;IPI008711
40 NP 
cDNA FLJ25678 fis, clone 
TST04067, highly similar to 
PURINE NUCLEOSIDE 
PHOSPHORYLASE;Purine 
nucleoside phosphorylase 2.5 8.41E-03 
IPI0046524
8 ENO1 
Isoform alpha-enolase of Alpha-
enolase 2.3 1.49E-03 
IPI0038247
0;IPI007842
95 HSP90AA1 
heat shock protein 90kDa alpha 
(cytosolic), class A member 1 
isoform 1;Isoform 1 of Heat 
shock protein HSP 90-alpha 2.2 2.46E-03 
IPI0041467
6 HSP90AB1 Heat shock protein HSP 90-beta 2.2 2.62E-03 
IPI0000007
0 LDLR Low-density lipoprotein receptor 2.1 3.77E-03 
IPI0001201
1 CFL1 Cofilin-1 2.0 7.35E-03 
IPI0001887
1;IPI007890
69 ARL8B;- 
cDNA FLJ56285, highly similar 
to ADP-ribosylation factor-like 
protein 8B;cDNA FLJ61158, 
highly similar to ADP-
ribosylation factor-like protein 
8B 2.0 7.90E-03 
IPI0001122
9 CTSD Cathepsin D 2.0 7.93E-03 
Mitochondria from Parkin-expressing HeLa S3 cells with and without CCCP (2 hours) were compared.   
*Combined ratio from three independent mass spectrometry experiments consisting of two independent 
biological samples and one technical replicate. The ratio represents the protein level in mitochondria of 
CCCP-treated cells divided by the level in untreated cells.  
^Corresponds to significance in MaxQuant	  
Supplementary Table 4⏐Non-MitoCarta proteins with decreased abundance in mitochondria of 
CCCP-treated cells 
Leading IPIs 
Leading 
Gene Names 
Leading Protein 
Descriptions 
Overall 
H/L 
Normalized 
Ratio* 
Overall  
H/L 
Significance^ 
IPI00852851;IPI00
008732 TRABD 
43 kDa protein;Isoform 1 of 
TraB domain-containing 
protein 0.19 3.64E-13 
IPI00432065 C11orf83 
Uncharacterized protein 
C11orf83 0.21 5.04E-12 
IPI00855998 CENPF Centromere protein F 0.21 6.20E-09 
IPI00640118 
LOC10013180
1 similar to hCG2036585 0.21 9.37E-09 
IPI00607900;IPI00
013278 C20orf149 
Chromosome 20 open reading 
frame 149;Isoform 1 of 
UPF0362 protein C20orf149 0.23 2.26E-08 
IPI00106646;IPI00
009794;IPI005147
55 SDF4 
45 kDa calcium-binding 
protein;stromal cell derived 
factor 4 precursor;Stromal cell 
derived factor 4 0.28 9.88E-09 
IPI00400948;IPI00
916639 C2orf64 
Uncharacterized protein 
C2orf64;8 kDa protein 0.29 1.57E-06 
IPI00168047;IPI00
845421 FAM73A 
Isoform 1 of Protein 
FAM73A;Isoform 2 of Protein 
FAM73A 0.30 2.57E-06 
IPI00009817;IPI00
878815 CHCHD8 
Isoform 2 of Coiled-coil-helix-
coiled-coil-helix domain-
containing protein 8;Isoform 1 
of Coiled-coil-helix-coiled-coil-
helix domain-containing 
protein 8 0.32 5.94E-10 
IPI00555820;IPI00
894163 MYO19 
cDNA FLJ61052, highly 
similar to Homo sapiens 
myosin head domain containing 
1 (MYOHD1), transcript 
variant 2, mRNA;Isoform 1 of 
Myosin-XIX 0.34 3.43E-07 
IPI00791574;IPI00
030531;IPI007945
66 SLMAP 
Isoform 1 of Sarcolemmal 
membrane-associated 
protein;Isoform 3 of 
Sarcolemmal membrane-
associated protein;Isoform 2 of 
Sarcolemmal membrane-
associated protein 0.34 5.55E-07 
IPI00017979;IPI00
478216 FAM54A 
Isoform 1 of Protein 
FAM54A;Isoform 2 of Protein 
FAM54A 0.35 3.78E-05 
IPI00877014;IPI00
290544 GDAP1 
ganglioside-induced 
differentiation-associated 
protein 1 isoform 
a;Ganglioside-induced 
differentiation-associated 
protein 1 0.40 1.85E-04 
IPI00014456;IPI00 STRN Isoform 1 of Striatin;Isoform 2 0.43 4.48E-04 
654594 of Striatin 
IPI00303753 C1orf163 
Hcp beta-lactamase-like protein 
C1orf163 0.45 7.83E-06 
IPI00514622 RANBP6 Ran-binding protein 6 0.48 4.08E-04 
IPI00465113;IPI00
915852 EXDL2 
cDNA FLJ58573, highly 
similar to Exonuclease 3'-5' 
domain-like-containing protein 
2;Exonuclease 3'-5' domain-
like-containing protein 2 0.50 4.19E-04 
IPI00015890 CCRN4L Nocturnin 0.52 3.47E-03 
IPI00413436 COX19 
Cytochrome c oxidase 
assembly protein COX19 0.53 1.36E-03 
IPI00295542;IPI00
893190 NUCB1 
Nucleobindin-1;cDNA 
FLJ52898, highly similar to 
Nucleobindin-1 0.55 2.54E-03 
IPI00465410 C12orf73 
Uncharacterized protein 
C12orf73 0.55 2.76E-03 
IPI00853224 STARD7 
StAR-related lipid transfer 
protein 7, mitochondrial 0.56 1.76E-03 
IPI00305552;IPI00
395372 CHCHD5 
cDNA FLJ39671 fis, clone 
SMINT2008917;Coiled-coil-
helix-coiled-coil-helix domain-
containing protein 5 0.57 9.07E-03 
IPI00024619 C16orf61 UPF0287 protein C16orf61 0.62 5.03E-03 
Mitochondria from Parkin-expressing HeLa S3 cells with and without CCCP (2 hours) were compared.   
*The protein level in the mitochondria of CCCP-treated cells divided by the level in untreated cells.  
^Corresponds to the significance in MaxQuant 
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